SWOG clinical trial number
E1295
Randomized Trial of High-Dose Versus Conventional Dose Octreotide Acetate Versus Loperamide in the Treatment of Chemotherapy-Related Diarrhea in Patients with Colorectal Cancer
Closed
Phase
Published
Abbreviated Title
Randomized Trial of High-Dose Versus Conventional Dose Octreotide Acetate Versus Loperamide in the Treatment of Chemotherapy-Related Diarrhea in Patients with Colorectal Cancer
Activated
01/15/1997
Closed
02/15/1999
Publication Information Expand/Collapse
2002
Randomized trial of standard dose loperamide, low-dose octreotide acetate, or high dose octreotide acetate for chemotherapy induced diarrhea (E1295): an Intergroup study of the Eastern Cooperative Oncology Group